Pyroptosis: A new insight of non-small-cell lung cancer treatment
- PMID: 36523974
- PMCID: PMC9746897
- DOI: 10.3389/fonc.2022.1013544
Pyroptosis: A new insight of non-small-cell lung cancer treatment
Abstract
Non-small cell lung cancer (NSCLC) has become one of the most common malignant tumors. Emerging evidence has shown that tumor resistance to apoptosis by damaging or bypassing apoptotic cell death is a major contributor to poor responses to therapy in patients with NSCLC. Pyroptosis is a new type of cytolytic and inflammatory programmed death distinct from apoptosis. Currently, pyroptosis has been reported to cause a strong inflammatory response and significant tumor suppression. It is considered a promising therapeutic strategy and prognosis for NSCLC. In this review, we summarized the characteristics of pyroptosis from its underlying basis and role in NSCLC, thereby providing the potential of pyroptosis as a therapeutic strategy and highlighting the challenges of activating pyroptosis in NSCLC treatment.
Keywords: NSCLC; prognosis; programmed cell death; pyroptosis; therapy.
Copyright © 2022 Chen, Wu and Wang.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures
Similar articles
-
Targeting lncRNAs in programmed cell death as a therapeutic strategy for non-small cell lung cancer.Cell Death Discov. 2022 Apr 4;8(1):159. doi: 10.1038/s41420-022-00982-x. Cell Death Discov. 2022. PMID: 35379783 Free PMC article. Review.
-
Simvastatin Suppresses Proliferation and Migration in Non-small Cell Lung Cancer via Pyroptosis.Int J Biol Sci. 2018 Mar 10;14(4):406-417. doi: 10.7150/ijbs.23542. eCollection 2018. Int J Biol Sci. 2018. PMID: 29725262 Free PMC article.
-
Huaier extract suppresses non-small cell lung cancer progression through activating NLRP3-dependent pyroptosis.Anat Rec (Hoboken). 2021 Feb;304(2):291-301. doi: 10.1002/ar.24307. Epub 2019 Nov 22. Anat Rec (Hoboken). 2021. Retraction in: Anat Rec (Hoboken). 2021 Dec;304(12):2899. doi: 10.1002/ar.24811 PMID: 31692261 Retracted.
-
Transcription Factor p53 Suppresses Tumor Growth by Prompting Pyroptosis in Non-Small-Cell Lung Cancer.Oxid Med Cell Longev. 2019 Oct 13;2019:8746895. doi: 10.1155/2019/8746895. eCollection 2019. Oxid Med Cell Longev. 2019. PMID: 31737176 Free PMC article.
-
Induction of Pyroptosis: A Promising Strategy for Cancer Treatment.Front Oncol. 2021 Feb 26;11:635774. doi: 10.3389/fonc.2021.635774. eCollection 2021. Front Oncol. 2021. PMID: 33718226 Free PMC article. Review.
Cited by
-
Pyroptosis: Induction and inhibition strategies for immunotherapy of diseases.Acta Pharm Sin B. 2024 Oct;14(10):4195-4227. doi: 10.1016/j.apsb.2024.06.026. Epub 2024 Jun 28. Acta Pharm Sin B. 2024. PMID: 39525577 Free PMC article. Review.
References
Publication types
LinkOut - more resources
Full Text Sources